Inflammation
Animal studies have reported anti-inflammatory activity in muscle, wound, arthritis, and gastrointestinal injury models.
BPC-157 · Coming soon
Still feeling the same tendon?
BPC-157
Studied for inflammation and tissue repair.
In animal research, BPC-157 has improved measures of tendon and ligament healing and shown anti-inflammatory activity across muscle, wound, arthritis, and gastrointestinal injury models. Human studies are still too limited to know how reliably those results carry over.
Be first to know when orders open.
Product updates and occasional emails. Unsubscribe anytime.
- Tendon and ligament healing studied directly in rats.
- Anti-inflammatory findings across several injury models.
- Licensed U.S. pharmacy fulfillment required for any Rebody prescription.
Why sourcing matters
Know what is in the vial.
A prescription filled by a licensed U.S. compounding pharmacy comes with a labeled formulation, strength, storage instructions, beyond-use date, and a traceable dispenser. If Rebody offers BPC-157, those details will be visible before you order.
What researchers have studied
Inflammation. Tendons. Ligaments. Muscle. Gut.
Tendon and ligament repair
Rat studies reported better functional, biomechanical, microscopic, and tissue-healing measures after Achilles tendon and ligament injuries.
Muscle, wound, and gut repair
Researchers have also studied BPC-157 in muscle, wound, blood-vessel, and gastrointestinal injury models.
Illustrative packagingBefore you order
See the strength, directions, pharmacy, and price.
StrengthPrinted on the label
DirectionsWritten in syringe units
Before ordering, you should be able to see the concentration, prescribed syringe units, days of supply, storage, refill timing, dispensing pharmacy, and price.
See BPC-157 detailsThe evidence
Animal studies across repair models. Very little human data.
BPC-157 has produced intriguing findings across inflammation, tendon, ligament, muscle, wound, blood-vessel, and gastrointestinal models. Useful human evidence remains scarce.
Inflammation
BPC-157 has shown anti-inflammatory activity in several animal injury models. Researchers have not yet established the same effect in people.
Tendons and ligaments
Rat studies reported better healing measures after Achilles tendon, ligament, and myotendinous injuries. Comparable clinical trials in people are still missing.
The unanswered question
Human evidence has yet to establish a standard subcutaneous dose, faster recovery, less pain, or a long-term safety profile for compounded BPC-157.
BPC-157 availability
Want to know when it’s available?
We’ll email you when Rebody has confirmed the price, pharmacy, strength, supply, and states served.
Coming soonOrders currently closed
Get BPC-157 availability updates.
Join the list for BPC-157 availability, price, pharmacy, strength, supply, and states served.
Product updates and occasional emails. Unsubscribe anytime.
BPC-157 questions
Before you put BPC-157 in your body.
Is BPC-157 available from Rebody now?
Not yet. Orders are closed. Join the interest list and we’ll email you when availability, price, pharmacy, strength, and states served are confirmed.
Does BPC-157 heal injuries?
Animal studies have reported improved functional, biomechanical, microscopic, and tissue-healing measures after tendon, ligament, and myotendinous injury, along with anti-inflammatory activity in other injury models. Those are meaningful preclinical findings. Human trials have not yet established the same predictable recovery benefit.
How would Rebody offer BPC-157?
The planned Rebody format is a subcutaneous injection filled by a licensed U.S. compounding pharmacy. The exact formulation, strength, directions, price, and availability will be included in the availability update.
Is compounded BPC-157 FDA-approved?
No. Compounded medications are not FDA-approved. A compounded BPC-157 prescription would be prepared for an individual patient by a licensed U.S. compounding pharmacy.